Author

Holly Cooper

Institution: Artios Pharma Limited (United Kingdom)

Observed institution: Artios Pharma Limited (United Kingdom)

ORCID: 0009-0004-7163-6329

Observed ORCID: 0009-0004-7163-6329

OpenAlex ID: A5140520148

The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy

2026 · Helen M.R. Robinson, Vera Grinkevich, et al. · Clinical Cancer Research · 2

Data from The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy

2026 · Helen M.R. Robinson, Vera Grinkevich, et al.

Supplementary Data1 from The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy

2026 · Helen M.R. Robinson, Vera Grinkevich, et al.

Works count: 3

Citation count: 2

H-index: 1

I10-index: